Baker Heart and Diabetes Institute
Baker Heart and Diabetes Institute is Australia’s only multidisciplinary organisation ded
icated to tackling cardiovascular disease, diabetes, and obesity. Founded on philanthropy, the Baker Institute has been responsible for ground-breaking developments for more than 95 years. These developments have changed the course of disease and saved the lives of millions of people in Australia and around the world. Under four pillars of research: Save Young Hearts; Keep Hearts Healthy; Prevent Failing Hearts; and Beat Diabetes.

The Baker Institute is taking a personalised approach in its mission to help Australians to live longer, healthier lives. By creating a personalised health signature, the Institute aims to predict disease risk long before symptoms develop. The Baker Institute is firmly committed to equity and diversity, and to going where the need is. This includes helping to improve the health of people in lower socioeconomic groups and those in remote communities.


Bionics Institute
The Bionics Institute is an internationally recognised, independent medical research institute that solves medical challenges with technology. They lead the world in the research and development of innovative medical devices and therapies to improve human health.

Their multidisciplinary team comprises world-class scientists, engineers and researchers, and their laboratories are located at St Vincent’s Hospital Melbourne, close to their clinical collaborators. Together they’re transforming the lives of people with a range of conditions, including Alzheimer’s disease, hearing impairment, Crohnʼs disease, limb loss, chronic pain, Parkinsonʼs disease, and arthritis.

Hearts & Minds is supporting the Institute’s work around the diagnosis and treatment of tinnitus.


Brain and Mind Centre

The University of Sydney’s Brain and Mind Centre (BMC) brings together a network of researchers and clinicians who partner across borders and disciplines in pursuit of a common goal: to develop better treatments for conditions of the brain and mind and improve health outcomes now and for future generations.

The BMC’s multidisciplinary research teams are at the forefront of brain and mind sciences. They work to find answers to some of the world’s most pressing health concerns across the lifespan, including childhood development and behaviour disorders, youth mental health and addiction, and the ageing brain and neurodegenerative disease.

Work at the Centre extends beyond laboratories and clinics and focus’ on translation through its strong partnerships with industry, government, the community, and other healthcare providers and researchers.

Hearts & Minds is currently supporting Dr Eleanor Drummond and Prof Glenda Halliday’s research into identifying the molecular drivers of Progressive Supranuclear Palsy, a rare neurological condition, and has previously also supported Professor Ian Hickie’s leading mental health research.


Centre for Population Genomics
A joint initiative between Murdoch Children’s Research Institute and Garvan Institute of Medical Research, the Centre for Population Genomics, led by Professor Daniel MacArthur seeks to create a world in which genomic information enables comprehensive disease prediction, accurate diagnosis and effective therapeutics for all people.

Genomic medicine uses the information in a person’s genes to guide disease diagnosis and decisions about suitable treatments. In the future, health will be based on an individualised model of care, informed by the data contained in a person’s genes.

Australia, thanks to its strengths in both research and healthcare, has an opportunity to be an international leader in the development of genomic medicine and its application to the entire population. But much remains to be done.


Cerebral Palsy Alliance Research Foundation
Cerebral palsy is the most common physical disability in childhood and a condition that affects the movement, posture and speech of 17 million people globally.

Cerebral Palsy Alliance Research Foundation was established by Cerebral Palsy Alliance in 2005 as a world first, dedicated to funding the best and brightest minds in cerebral palsy research globally to drive major achievements in prevention, treatment and cure. The foundation has developed a reputation as a world leader in cerebral palsy research, re-writing the future for those living with cerebral palsy and driving discoveries expected to have a transformational impact for a range of other neurological conditions and disorders including spinal cord injury, brain traumas, stroke, Parkinson’s, dystonia, epilepsy, autism and many more. Since 2005, the foundation has invested $60 million dollars to the study and implementation of preventions, and is committed to the advancement of treatments for those who are living with cerebral palsy.


Epworth Centre for Immunotherapies and Snowdome Laboratories
Epworth believes that the more we understand, the better we can treat and care for our patients.

Epworth is committed to providing the best possible care for all of our patients. As part of this commitment, we invest in world-class equipment, professional development of our staff, and research to find innovative treatments to improve the lives of our patients and their families.

To this end, the Epworth Centre for Immunotherapies and Snowdome Laboratories was established in 2020, under the direction of internationally recognised haematologist, Professor Miles Prince AM. This centre of excellence leads a number of clinical trials to improve blood cancer treatment so that Australians no longer have to travel abroad to access the most advanced treatment options available.

Every day, more than 50 people in Australia are diagnosed with blood cancer.

While blood cancers are classified as a group, each person has a unique experience and treatment needs. This is why the Centre is committed to identifying and tailoring innovative, personalised treatments for each and every person with blood cancer.

The Centre is currently running haematology clinical trials to find better treatments for blood cancers and undertaking research in the fields of genomics and cancer immunology.

Epworth established the Autologous Stem Cell Transplantation Service in 2023 - the first in a private hospital in Victoria, and only the second in Australia - to provide this treatment option for patients with lymphoma and multiple myeloma.

This transplant service is a specialised multi-step process with various stages of patient treatment and admissions in the Day Oncology Unit and Ward 2 East at Epworth Freemasons hospital.

This is an important step in realising our main objective – to deliver CAR-T Cell Therapy, one of the most revolutionary advances in medical science in recent years. CAR-T involves manipulating the genetic material (DNA) of the patient’s cancer-fighting white blood cells, so that these ‘armoured’ immune cells can then fight and kill cancer cells.

The Centre is on the cusp of an exciting future and delighted that Hearts and Minds Investments is partnering in its life-saving work.


The Florey Institute of Neuroscience and Mental Health
The Florey Institute of Neuroscience and Mental Health (Florey Institute) is one of the largest and highly respected brain research centres in the world.

The Florey Institute works on a range of serious diseases including stroke, epilepsy, Alzheimer’s, Parkinson’s and motor neurone diseases, depression and addiction (amongst others). The Florey Institute is a world leader in imaging technology, stroke rehabilitation and large population studies to improve patient care around the world.

The Florey Institute is committed to finding causes, treatments and cures for conditions affecting the brain and mind and are seeking ways to help people live without suffering and to improve health on a global scale.

Dementia Centre

HammondCare - The Dementia Centre
Older and younger people living with dementia need access to services designed to support their unique and specific needs.

The Dementia Centre gathers experts to advance research and global best practice in dementia care. This is achieved by building and sharing dementia knowledge and supporting others in improving practice for people living with dementia and with complex behavioural needs worldwide.

The six core focus areas of The Dementia Centre are research, models of care, understanding behavior, design and the environment, palliative care, and engagement.


The Children's Hospital at Westmead – Kids Critical Care Research
The Children's Hospital at Westmead treats over 81,000 children a year from across NSW, Australia and the Pacific Rim. With over 57,000 Emergency Department presentations and 859,000 outpatient visits, the Children's Hospital at Westmead is the place that cares for the sickest kids. Supported by the Sydney Children's Hospitals Foundation the Children's Hospital at Westmead relies significantly on philanthropic support to fund research across the hospital. Through Lab-based discovery science and biomedical research the Children's Hospital at Westmead translates research results into clinical practice.

Caring for the youngest patients the Paediatric Intensive Care Unit (PICU) is a 21-bed unit providing supportive care to 1400 infants, children and adolescents each year. Patients come to PICU with the entire spectrum of critical care problems. Patients may be admitted following surgery including cardiac surgery, neurosurgery, liver or renal transplant or with a range of other conditions such as respiratory illness, trauma, burns or other severe medical conditions as well as an outreach service.

Research within PICU is focused on ensuring the very best chance of survival of the youngest patients after major surgery as well as minimising the long-term health effects that can result from such intrusive procedures.


Muscular Dystrophy NSW

Muscular Dystrophy NSW is NSW’s leading not-for-profit organisation dedicated to supporting people living with a neuromuscular condition and their families at every life stage.

For over 60 years, MDNSW have connected people across NSW living with neuromuscular conditions to the support programs they want, and the community they need.

MDNSW’s mission is to empower, connect and support the neuromuscular communityand be an effective advocate for the neuromuscular community.

They achieve this by providing:

  • A strong commitment to research into progressive treatments for neuromuscular conditions, raising funds to sponsor individual researchers and research institutions as well as partnering with local neuromuscular clinics and relevant bodies including the Australian Neuromuscular Disease Registry (ANMDR) to spread knowledge and raise awareness.
  • Advocacy of causes important to the neuromuscular community including accessibility, NDIS reform and inclusion.
  • Information, support coordination and peer support.
  • Events, camps, and retreats that bring people in the community together to share, learn from and support each other.


Neuroscience Research Australia (NeuRA) is an independent, not-for-profit research institute based in Sydney, Australia. For over three decades, researchers at NeuRA have been dedicated to advancing medical science, aiming to prevent, treat, and cure brain and nervous system diseases, disorders and injuries. NeuRA’s research is diverse, spanning dementia, mental health, chronic pain and falls prevention. With a vision to enhance the lives of those affected by neurological challenges, our mission is to discover innovative solutions for neurodegeneration, mental health issues, and healthy ageing through world-class medical research.


Pain Management Research Institute
Pain Foundation Ltd is the not-for-profit organisation with DGR status that helps provide secure funding to the researchers and clinicians of the Pain Management Research Institute (PMRI).

PMRI is a Research Centre of the Faculty of Medicine and Health, University of Sydney and a Centre of the Kolling Institute of Medical Research, a joint initiative between the University and Northern Sydney Local Health District. PMRI has been leading the way in the science and treatment of pain since 1990.

Pain Foundation Ltd and PMRI together pursue our broad goal of becoming a global leader in providing comprehensive pain management solutions, lifting the burden of pain from the community. This is done by conducting basic/pre-clinical, clinical and applied research programs; operating a national and international education program; and in collaboration with the Michael J Cousins Pain Management & Research Centre (PMRC), treating patients with acute pain, cancer pain, and chronic non-cancer pain.


The Harry Perkins Institute of Medical Research
The Harry Perkins Institute of Medical Research conducts innovative research into the diseases that most affect our families in the WA community and the world at large.

The Perkins was established in 1998 to unify Western Australian scientists in a collaborative research powerhouse. In the years since, we have grown to become one of the nation’s leading medical research centres, where a close knit team of more than 250 research and trial staff work together to defeat the major diseases that impact our community – diseases like cancer, heart disease, diabetes and rare genetic diseases.


Royal Prince Alfred Hospital, research
Royal Prince Alfred Hospital (RPA), in Sydney Local Health District, is one of Australia's premier tertiary referral hospitals and is recognised as a worldwide leader in healthcare excellence and innovation.

RPA is a centre of excellence for medical research, known internationally for pioneering highly complex interventions and novel treatments and as a training ground for the next generation of clinicians.

The team of experienced clinicians in the RPA Emergency Department cares for patients and their families 24 hours a day, every day of the year. Supporting RPA research will help them drive advancements in translational research improving trauma, emergency and critical care. Moneys donated to RPA will be preferentially directed to supporting research in emergency medicine, critical care and related fields.


SpinalCure Australia
SpinalCure Australia has been Australia’s pioneer and leader in the funding and promotion of cure-related SCI research for 30 years. Over the past five years, SpinalCure has raised over $30 million to help accelerate life-changing research in this area.

More than 20,000 Australians live with an SCI and the burden to the economy is enormous, with SCI having an estimated lifetime cost of $75.4 billion.

Living with an SCI is hugely devastating. Reaching far beyond having an inability to walk, an SCI often leads to a loss of other bodily functions such as bladder and bowel control and impacts a person’s mental health, independence and freedom as they become more reliant on the help and care of others.

SpinalCure’s work is focused on three areas: advancing neurostimulation (a potentially revolutionary treatment for people with SCI), progressing early intervention via neuroprotection research and strengthening the SCI industry through advocacy work and planning treatment roll-out.

Through collaborations with universities, government, business, community and philanthropists, SpinalCure is highly targeted with its research funding and focused on looking for results and real improvements in patient outcomes. To meet this end, SpinalCure’s international Scientific Advisory Panel helps it select the very best scientists and therapies to ensure SpinalCure can move closer to the goal of finding a cure for SCI. 


St Vincent's Clinic Research Foundation
The primary focus of St Vincent's Clinic Research Foundation is supporting critical medical research across St Vincent's Sydney Health Innovation Precinct. With over 30 years of history, funding is provided to advanced research and projects in their infancy that require support to flourish. The grants enable opportunities for future medical breakthroughs that are making a high impact globally. 


Turning Point
Turning Point is a national treatment, research and education centre that provides leadership in the alcohol and other drug, gambling and mental health sectors.

Combining innovative clinical and population health research and expert policy advice with service innovation, surveillance, system enhancements, capacity building and specialist support, Turning Point empowers people, communities, services and governments to respond to current and emerging alcohol, other drug, and gambling harms.

Turning Point is part of Eastern Health and is affiliated with Monash University.

Turning Point’s work has helped to transform lives, with more than 100,000 Australians seeking support from their highly skilled clinicians every year.

Their research and health surveillance teams inform new cutting-edge treatments and shape health and social policy, while their workforce training equips frontline staff with the skills and confidence to respond and treat addiction.

Turning Point aims to address addiction issues across the spectrum of harm, establishing effective methods for supporting client journeys from initial help-seeking through to specialist treatment and recovery. 


Victor Chang Cardiac Research Institute
The Victor Chang Cardiac Research Institute (Victor Chang Institute) is recognised as one of the world’s premier research institutes for cardiovascular disease which kills more people than any other disease in the world.

Internationally recognised for the quality of its discoveries, the Victor Chang Institute has pioneered the use of novel transplantation techniques, advanced stem cell research, bioengineering, structural biology, complex molecular and genetic analyses to diagnose, treat and ultimately prevent cardiovascular disease.


WEHI (Walter and Eliza Hall Institute of Medical Research)
WEHI (Walter and Eliza Hall Institute of Medical Research) is where the world’s brightest minds collaborate and innovate to make discoveries that will help people in Australia and around the world live healthier, longer lives. The Institute has been serving the community for 107 years, bringing together multidisciplinary research teams - people with different skills and experience who are committed to long-term scientific discovery, balanced by a sense of urgency to provide hope to people now.

WEHI’s research areas address the biggest health problems facing our community today. They include devastating diseases like incurable cancers, dementia, immune diseases and infectious diseases. The development and application of new medicines, of new technology and sophisticated bioinformatics keep WEHI at the forefront of medical discovery in Australia.


How are our beneficiaries nominated?

Learn about our story that was built with a philanthropic vision with the combined objective of providing a concentrated equities portfolio of the highest conviction ideas from leading fund managers, whilst also supporting Australian medical research institutes.